Rawalpindi hospitals face free medicine crisis as Punjab withholds ₹2 billion funds
Synopsis
Key Takeaways
Three major government hospitals in Rawalpindi, Pakistan are on the verge of halting free medicine supplies to patients after the Punjab government failed to release PKR 2 billion in promised funds, local media reported on 1 June 2026. The shortfall threatens the free medicine programme at Holy Family Hospital (HFH), Benazir Bhutto Hospital (BBH), and Rawalpindi Teaching Hospital (RTC), potentially affecting thousands of outdoor, indoor, and emergency patients.
The Funding Shortfall
The three hospitals had collectively requested a budget of PKR 4.5 billion for the fiscal year 2025-26. The Punjab government released only PKR 2.5 billion and pledged to disburse the remaining PKR 2 billion by May 2026 — a commitment it has not honoured, according to reports citing a senior official at HFH.
The individual gaps are stark. HFH requested PKR 1.5 billion but received only PKR 400 million. Benazir Bhutto General Hospital (BBGH) sought PKR 1.5 billion and was allocated just PKR 380 million. RTC asked for PKR 1 billion and received PKR 250 million, according to reports quoting Pakistani daily Dawn.
Vendors Refuse Further Supplies
Medicine stocks at all three hospitals are reported to have lasted only until 30 June. With no funds available to clear outstanding dues, distributors and vendors have refused to extend further credit. 'If funds are not released, the distributors will not provide medicines for the next month,' the senior HFH official said, as quoted by Dawn.
The official warned that the situation 'will deteriorate in coming days when the hospitals will not provide any free medicines to patients.' He noted that the Punjab government had itself mandated these hospitals to supply free medicines to outdoor, indoor, emergency, and admitted patients — making the funding failure a direct policy contradiction.
Wider Healthcare Context
The crisis arrives against an already alarming public health backdrop. Last month, the WHO's Global Hepatitis Report 2026 identified Pakistan as the single largest contributor to the global count of people living with hepatitis C. Pakistan is also among the 10 nations that accounted for 58 per cent of the world's hepatitis C-linked deaths in 2024.
Field reports from multiple Pakistani cities, cited by daily The News International, have found continued availability of banned reusable syringes and fake auto-disable syringes in the market. Health experts warn these can fuel transmission of hepatitis B, hepatitis C, and HIV when used repeatedly by unqualified practitioners. An editorial in The News International noted that 'unnecessary injections and quackery remain common in Pakistan, and infection prevention practices are poorly enforced in both formal and informal healthcare settings.'
What Happens Next
Unless the Punjab government releases the pending PKR 2 billion immediately, the free medicine programme at Rawalpindi's three largest public hospitals faces a complete breakdown from July 2026. With Pakistan's public health infrastructure already under strain from hepatitis and supply-chain vulnerabilities, the funding impasse risks compounding an existing crisis for patients who have no private alternatives.